Detalhe da pesquisa
1.
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy.
ACS Nano
; 16(6): 8729-8750, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616289
2.
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice.
J Clin Invest
; 131(4)2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332283